Lineage Cell Therapeutics (LCTX) Payables (2010 - 2026)
Lineage Cell Therapeutics' Payables came in at $5.39 million for Q2 2026, up 21.0% from $4.45 million a year earlier but down 3.2% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Payables was $7.18 million, up 32.1% from FY2024.
- Payables carries a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
- Going back by year, Payables was $5.44 million in FY2024 (-13.3%), $6.27 million in FY2023 (-27.2%), $8.61 million in FY2022 (-69.2%) and $27.97 million in FY2021 (+310.5%).
- The five-year range for quarterly Payables is $4.45 million (Q2 2025) to $27.97 million (Q4 2021).
- Year-over-year, Payables has increased for four consecutive quarters, with growth averaging 2.3% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q4 2021 (growth of 310.5%), and the weakest in Q4 2022 (a decline of 69.2%).
- Business Quant data shows LCTX's Payables at $5.57 million (Q1 2026), $7.18 million (Q4 2025) and $4.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.57 Bn | 1,108.15 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 634.50 Bn | 554.36 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 500.91 Bn | 474.02 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 355.88 Bn | 310.26 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 300.26 Bn | 264.25 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 263.05 Bn | 236.74 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.74 Bn | 193.14 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.00 Bn | 168.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.20 Bn | 116.85 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Lineage Cell Therapeutics | 246.75 Mn | 46.28 Mn | - | 5.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.39 Mn |
| Mar 31, 2026 | 5.57 Mn |
| Dec 31, 2025 | 7.18 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 5.02 Mn |
| Mar 31, 2024 | 5.68 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Dec 31, 2022 | 8.61 Mn |
| Sep 30, 2022 | 9.81 Mn |
| Jun 30, 2022 | 8.68 Mn |
| Mar 31, 2022 | 8.96 Mn |
| Dec 31, 2021 | 27.97 Mn |
| Sep 30, 2021 | 6.71 Mn |
API Access
Lineage Cell Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();